Bristol Myers Squibb drug Augtyro now has a tumor-agnostic approval permitting the drug to be used to treat all solid tumors positive for NTRK gene fusions. Augtyro came from BMS’s $4.1 billion acquisition of Turning Point Therapeutics. The post New FDA Nod Brings Bristol Myers Squibb Cancer Drug to a Wider Range of Solid Tumors appeared first on MedCity...

This week, Wheel rolled out a new AI-powered platform designed to provide patients with more holistic and seamless virtual care journeys. The platform, called Horizon, aims to help the startup’s customers rapidly scale virtual care programs to meet growing patient demand. The post Wheel’s New AI Platform Seeks to Power the New Era of Virtual Care appeared...

Better Health’s $14 million in funding included investments from Healthworx, the University of Miami Health System and Mosaic General Partnership. The post Better Health Raises $14M To Reach More Patients with Chronic Conditions appeared first on MedCity News.

Solving this problem will require a multi-pronged approach that includes recruitment, technology, and help from lawmakers. The post Addressing Healthcare Workforce Shortages Beyond Band-Aids appeared first on MedCity News.

Cutting-edge technology empowers developers to proactively detect and mitigate issues before they cause problems, reducing recalls and fostering trust in the industry. The post From Recalls to Reliability: Tools to Ensure Software Safety in MedTech appeared first on MedCity News.

The Supreme Court sided with the FDA and unanimously ruled to uphold access to abortion pill mifepristone. The decision quells worries about what it might look like if the Supreme Court sided with the physician group — many healthcare leaders feared that if the top court could overturn mifepristone’s FDA approval, the same could happen to other drugs....